|
ZNF680 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.219700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.075900E-03 |
| Normal-vs-Stage2 |
4.970400E-01 |
| Normal-vs-Stage3 |
5.735100E-03 |
| Normal-vs-Stage4 |
5.457800E-01 |
| Stage1-vs-Stage2 |
3.828200E-01 |
| Stage1-vs-Stage3 |
4.532200E-01 |
| Stage1-vs-Stage4 |
6.040800E-01 |
| Stage2-vs-Stage3 |
2.095600E-01 |
| Stage2-vs-Stage4 |
9.193000E-01 |
| Stage3-vs-Stage4 |
3.538400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.683000E-03 |
| Normal-vs-AfricanAmerican |
9.624100E-02 |
| Normal-vs-Asian |
2.991900E-02 |
| Caucasian-vs-AfricanAmerican |
8.721400E-01 |
| Caucasian-vs-Asian |
2.035000E-01 |
| AfricanAmerican-vs-Asian |
2.561000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.783000E-03 |
| Normal-vs-Female |
9.723900E-02 |
| Male-vs-Female |
6.419000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.734200E-02 |
| Normal-vs-Extreme_Weight |
2.001900E-03 |
| Normal-vs-Obese |
1.993770E-02 |
| Normal-vs-Extreme_Obese |
9.148200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.288600E-01 |
| Normal_Weight-vs-Obese |
9.069200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.464600E-01 |
| Extreme_Weight-vs-Obese |
5.411000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.338200E-01 |
| Obese-vs-Extreme_Obese |
4.261400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.91714999999704E-05 |
| Normal-vs-Age(41-60Yrs) |
6.880100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.436270E-02 |
| Normal-vs-Age(81-100Yrs) |
2.241900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.084400E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.749700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.170400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.759600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.471200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.721800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.875900E-02 |
| Normal-VS-Type2 PRCC |
6.622800E-03 |
| Normal-VS-KIRP CIMP |
2.01969999999996E-05 |
| Normal-VS-Unclassified PRCC |
1.580960E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.479760E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.563200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.664600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.599600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.643600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.897800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.417000E-04 |
| Normal-vs-N1 |
5.216400E-01 |
| Normal-vs-N2 |
9.379500E-04 |
| N0-vs-N1 |
1.064570E-01 |
| N0-vs-N2 |
1.582240E-01 |
| N1-vs-N2 |
1.155960E-01 |
|
|
